Aardvark Therapeutics AARD
NASDAQ AARD
$4.99 -0.28 (-5.31%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aardvark Therapeutics (AARD) Short-term Investments (2024 - 2026)

Updated

Aardvark Therapeutics (AARD) posted Short-term Investments of $21,000 for Q2 2026, down 100.0% from $115.82 million a year earlier and down 99.9% from the prior quarter.

Analysis

Aardvark Therapeutics (AARD) Short-term Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, Aardvark Therapeutics' Short-term Investments came in at $62.98 million, up 423.8% from FY2024.

  • In prior years, Aardvark Therapeutics' Short-term Investments was $12.02 million in FY2024.
  • According to Business Quant data, Short-term Investments for the three prior quarters was $28.76 million (Q1 2026), $62.98 million (Q4 2025) and $87.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Aardvark Therapeutics 115.33 Mn 41.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21,000.00
Mar 31, 2026 28.76 Mn
Dec 31, 2025 62.98 Mn
Sep 30, 2025 87.07 Mn
Jun 30, 2025 115.82 Mn
Mar 31, 2025 124.76 Mn
Dec 31, 2024 12.02 Mn
API Access

Aardvark Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=AARD&period=max&api_key=YOUR_API_KEY